| For: | Zhang YJ, Wu HC, Yazici H, Yu MW, Lee PH, Santella RM. Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B1 exposure. World J Hepatol 2012; 4(5): 169-175 [DOI: 10.4254/wjh.v4.i5.169] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v4/i5/169.htm |
| Number | Citing Articles |
| 1 |
Dieter Schrenk, Margherita Bignami, Laurent Bodin, James Kevin Chipman, Jesús del Mazo, Bettina Grasl‐Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Jean‐Charles Leblanc, Carlo Stefano Nebbia, Elsa Nielsen, Evangelia Ntzani, Annette Petersen, Salomon Sand, Tanja Schwerdtle, Christiane Vleminckx, Doris Marko, Isabelle P Oswald, Aldert Piersma, Michael Routledge, Josef Schlatter, Katleen Baert, Petra Gergelova, Heather Wallace. Risk assessment of aflatoxins in food. EFSA Journal 2020; 18(3) doi: 10.2903/j.efsa.2020.6040
|
| 2 |
Anne-Sophie Voisin, Victoria Suarez Ulloa, Peter Stockwell, Aniruddha Chatterjee, Frédéric Silvestre. Genome-wide DNA methylation of the liver reveals delayed effects of early-life exposure to 17-α-ethinylestradiol in the self-fertilizing mangrove rivulus. Epigenetics 2022; 17(5) doi: 10.1080/15592294.2021.1921337
|
| 3 |
X. Li, J. Gao, K. Huang, X. Qi, Q. Dai, X. Mei, W. Xu. Dynamic changes of global DNA methylation and hypermethylation of cell adhesion-related genes in rat kidneys in response to ochratoxin A. World Mycotoxin Journal 2015; 8(4) doi: 10.3920/WMJ2014.1795
|
| 4 |
Selcen Çelik‐Uzuner. Enhanced immunological detection of epigenetic modifications of DNA in healthy and cancerous cells by fluorescence microscopy. Microscopy Research and Technique 2019; doi: 10.1002/jemt.23365
|
| 5 |
Yuhua Shan. Aflatoxin B1 Occurrence, Detection and Toxicological Effects. 2020; doi: 10.5772/intechopen.88775
|
| 6 |
Smita Kumari, Jyotsna Misra, Niraj Kumar Jha, Naveen Kumar, Karthikeyan Ravi, Rohan Gupta. Foodborne Mycotoxins as Molecular and Epigenetic Carcinogens: Biochemical Mechanisms and Toxicological Implications. Journal of Biochemical and Molecular Toxicology 2026; 40(4) doi: 10.1002/jbt.70794
|
| 7 |
Elizabeth M. Martin, Rebecca C. Fry. Environmental Influences on the Epigenome: Exposure- Associated DNA Methylation in Human Populations.
Annual Review of Public Health
2018; 39(1) doi: 10.1146/annurev-publhealth-040617-014629
|
| 8 |
Priyanka Soni, Md. Sajid Ghufran, Santosh R. Kanade. Aflatoxin B1 induced multiple epigenetic modulators in human epithelial cell lines. Toxicon 2018; 151 doi: 10.1016/j.toxicon.2018.07.011
|
| 9 |
André Nogueira da Costa, Zdenko Herceg. Detection of cancer‐specific epigenomic changes in biofluids: Powerful tools in biomarker discovery and application. Molecular Oncology 2012; 6(6) doi: 10.1016/j.molonc.2012.07.005
|
| 10 |
Yujing Zhang. Cancer Epigenetics. Methods in Molecular Biology 2015; 1238 doi: 10.1007/978-1-4939-1804-1_37
|
| 11 |
Linda Rieswijk, Sandra M.H. Claessen, Otto Bekers, Marcel van Herwijnen, Daniël H.J. Theunissen, Danyel G.J. Jennen, Theo M.C.M. de Kok, Jos C.S. Kleinjans, Simone G.J. van Breda. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology 2016; doi: 10.1016/j.tox.2016.05.002
|
| 12 |
Dan Liu, Pengfei Liu, Liye Cao, Quan Zhang, Yaqing Chen. Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles. Oncology Letters 2017; 14(4) doi: 10.3892/ol.2017.6673
|
| 13 |
Matthew C. Sinton, David C. Hay, Amanda J. Drake. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0702-5
|
| 14 |
|
| 15 |
Yaqi Dai, Kunlun Huang, Boyang Zhang, Liye Zhu, Wentao Xu. Aflatoxin B1-induced epigenetic alterations: An overview. Food and Chemical Toxicology 2017; 109 doi: 10.1016/j.fct.2017.06.034
|
| 16 |
Marcel Padovani Giolo, Christiane Minervino de Oliveira, Dennis Armando Bertolini, Maria Valdrinez Campana Lonardoni, Matheus Sampaio Gouveia, Daisy Pontes Netto, Suzana Lucy Nixdorf, Miguel Machinski Junior. Aflatoxin M1 in the urine of non-carriers and chronic carriers of hepatitis B virus in Maringa, Brazil. Brazilian Journal of Pharmaceutical Sciences 2012; 48(3) doi: 10.1590/S1984-82502012000300011
|
| 17 |
Martha M. Moore, Rita S. Schoeny, Richard A. Becker, Kimberly White, Lynn H. Pottenger. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Critical Reviews in Toxicology 2018; 48(4) doi: 10.1080/10408444.2017.1423462
|
| 18 |
Oluwakemi A. Rotimi, Chinonye D. Onuzulu, Alisa L. Dewald, Jessa Ehlinger, Isaacson B. Adelani, Olutola E. Olasehinde, Solomon O. Rotimi, Jaclyn M. Goodrich. Early Life Exposure to Aflatoxin B1 in Rats: Alterations in Lipids, Hormones, and DNA Methylation among the Offspring. International Journal of Environmental Research and Public Health 2021; 18(2) doi: 10.3390/ijerph18020589
|
| 19 |
Jiao Lv, Ziyi Zhao. Binding of LINE-1 RNA to PSF transcriptionally promotes GAGE6 and regulates cell proliferation and tumor formation in vitro. Experimental and Therapeutic Medicine 2017; 14(2) doi: 10.3892/etm.2017.4667
|
| 20 |
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma. Translational Research 2019; 204 doi: 10.1016/j.trsl.2018.09.001
|
| 21 |
Carrie V. Breton, Carmen J. Marsit, Elaine Faustman, Kari Nadeau, Jaclyn M. Goodrich, Dana C. Dolinoy, Julie Herbstman, Nina Holland, Janine M. LaSalle, Rebecca Schmidt, Paul Yousefi, Frederica Perera, Bonnie R. Joubert, Joseph Wiemels, Michele Taylor, Ivana V. Yang, Rui Chen, Kinjal M. Hew, Deborah M. Hussey Freeland, Rachel Miller, Susan K. Murphy. Small-Magnitude Effect Sizes in Epigenetic End Points are Important in Children’s Environmental Health Studies: The Children’s Environmental Health and Disease Prevention Research Center’s Epigenetics Working Group. Environmental Health Perspectives 2017; 125(4) doi: 10.1289/EHP595
|
| 22 |
Jean-Baptiste Aholia Adépo, Pierre Manda, Jean Verdier Ngbé, Aïssata Diakité, Béatrice Tigori Sangaré, Sébastien Djédjé Dano. Study of aflatoxicosis reduction: effect ofAlchornea cordifoliaon biomarkers in an aflatoxin B1 exposed rats. Drug and Chemical Toxicology 2019; 42(3) doi: 10.1080/01480545.2017.1416625
|
| 23 |
Tae-Young Kim, Jae-Hee Park, Yong Wook Jung, Jae-Ho Lee, Jongwan Kim. Integrated Bioinformatics and Multi-Omics Analysis of ZBTB40 Expression, Prognostic Relevance, and Regulatory Networks in Hepatocellular Carcinoma. Medicina 2026; 62(7) doi: 10.3390/medicina62071244
|
| 24 |
Hipolito Otoniel Miranda-Roblero, Liliana Faridi Saavedra-Salazar, Marina Galicia-Moreno, Scarlet Arceo-Orozco, Fernando Caloca-Camarena, Ana Sandoval-Rodriguez, Jesús García-Bañuelos, Claudia Frias-Gonzalez, Mónica Almeida-López, Erika Martínez-López, Juan Armendariz-Borunda, Hugo Christian Monroy-Ramirez. Pirfenidone Reverts Global DNA Hypomethylation, Promoting DNMT1/UHRF/PCNA Coupling Complex in Experimental Hepatocarcinoma. Cells 2024; 13(12) doi: 10.3390/cells13121013
|
| 25 |
Pierre Manda, Aholia Jean-Baptiste Adépo, Alphonsine Kouassi M’bengue, Michel Konan, Jean Verdier N’gbe, Moussa Doumbia, Toussaint Toutou, Sébastien Djédjé Dano. Évaluation du rôle de l’aflatoxine B1 dans l’apparition du carcinome hépatocellulaire en Côte d’Ivoire : étude préliminaire. Toxicologie Analytique et Clinique 2018; 30(2) doi: 10.1016/j.toxac.2018.02.001
|